According to their website, Nutra Pharma is announcing that they have made capital improvements to their fulfillment center and warehouse to handle the increase in sales of the Company’s over-the-counter (OTC) pain reliever, Nyloxin®.  These improvements include: new rack systems throughout the facility, the purchase of a forklift, new management software as well as hiring additional staff.

Nyloxin® is an over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain.  Nyloxin® is currently available in the United States as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress. In addition to its everyday strength formulation, Nyloxin® is also offered in an extra strength formula for more advanced, Stage 3, chronic pain.

To learn more about the product, or the company, please visit my site.